PWM
RXST icon

Palumbo Wealth Management’s RxSight RXST Stock Holding History

Palumbo Wealth Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,789
Closed -$321K – 231
2025
Q4 		$321K Buy
30,789
+6,822
+28% +$68.5K 0.08% 163
2025
Q3 		$215K Buy
+23,967
New +$210K 0.07% 167

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Palumbo Wealth Management's RXST Position: Q1 2026 in Review

Palumbo Wealth Management sold out of RxSight (RXST) in Q1 2026, closing a stake of 30,789 shares — an estimated $321K sold.

Palumbo Wealth Management first reported a position in RXST in Q3 2025 and held it in 2 quarters. The position peaked at $321K in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Palumbo Wealth Management reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • Palumbo Wealth Management sold 30,789 RxSight shares in Q1 2026, an estimated $321K.
  • Palumbo Wealth Management first reported a position in RxSight in Q3 2025 and held it in 2 quarters.
  • Palumbo Wealth Management's RxSight position peaked at $321K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Palumbo Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.